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The objectives of this study were to determine the ability of the 30-, 15- and 8-item versions of the GDS for
screening and assessing change in severity of depression in nursing home patients. The GDS and the MADRS
were administered to 350 elderly NH-patients by trained interviewers. The presence of major (MaD) or minor
depression (MinD) was evaluated with the Schedules for Clinical Assessment in Neuropsychiatry. Receiver
Operator Characteristic (ROC) curves of the GDS-versions were performed to measure the ability to screen
on depression. The ability to measure change in severity of depression was measured by differences in mean
GDS-scores and mean MADRS-scores between patients with MaD, MinD and no depression, and expressed in
terms of effect sizes. It was found that in ROC-curves all three GDS-versions performed well. The MADRS
showed larger effect sizes for the differences between MaD, MinD and no depression than the GDS-versions.
The effect sizes of the three GDS versions were comparable. We conclude that all three versions of the GDS can
be used for screening on depression among NH-patients. The MADRS is superior to the GDS for assessment of
(changes in) severity of depression, but the GDS also appears to be an acceptable instrument for this purpose and
is less time-consuming.
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Introduction
Depression is a common psychiatric disorder in
nursing home patients, with prevalence rates ranging
from 6–26% for major depression and from 11–50%
for minor depression (Jongenelis et al., 2003). Given
the consequences of depression, such as its impact
on well-being and the associated excess mortality,
disability and healthcare utilisation (Beekman, Deeg,
Braam, Smit, & Van Tilburg, 1997; Beekman et al.,
2002; Rovner et al., 1991; Smalbrugge et al., 2006;
Wells, Steward, & Hays, 1989), accurate and timely
diagnosis and treatment are important. However, both
recognition and treatment of depression by nursing
home staff is reported to be poor (Bagley et al., 2000;
Boyle et al., 2004; Rovner, 1993).
For screening purposes, the Geriatric Depression
Scale (GDS) has been shown to be a valid and reliable
instrument among institutionalized elderly (Gerety,
Williams et al., 1994; McGivney, Mulvihill, & Taylor,
1994; Jongenelis et al., 2005; Lesher, 1986; Yesavage
et al., 1983). The GDS was developed to be self-
administered, but in frail nursing home patients it is
frequently administered in an interview (Jongenelis
et al., 2007).
Instruments specifically developed to assess the
severity of depression and to monitor the effects
of treatment include the Montgomery A˚sberg
Depression Rating Scale (MADRS) (Montgomery &
A˚sberg, 1979) and the Hamilton Depression Rating
Scale (HAM-D) (Hamilton, 1967). In physically ill
patients the MADRS proved more reliable than the
HAM-D (Hammond, 1998). The MADRS therefore
appears to be a more suitable instrument for measuring
the severity of depressive symptoms in the nursing
home setting. The MADRS is based on interview and
observation by trained clinicians.
It would, however, highly facilitate the manage-
ment of depressive disorders in nursing homes if one
instrument could cover both the screening and the
assessment of (change in) severity of depression.
The present study compares three GDS-versions
(the 30-, 15- and 8-item versions) on their efficacy as a
screening device for depression among nursing home
patients and it compares these three GDS-versions and
the MADRS on their ability to measure (changes in)
severity of depression.
Methods
Study population
This study is based on data collected in the Amsterdam
Groningen Elderly Depression (AGED) study
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(Jongenelis et al., 2004). Fourteen nursing homes in the
north west of the Netherlands were selected
to participate. Nursing homes for specific disease
categories were excluded, as were small nursing
homes (560 beds). No large reorganization or
rebuilding activities were allowed because of possible
influence on the mood of the respondents. To be
eligible, subjects had to be aged 55 years and over and
able to communicate sufficiently, without serious
hearing problems or severe cognitive impairment
(Mini-Mental State Examination [MMSE] 15)
(Folstein, Folstein, & Mchugh, 1975). All eligible
patients were informed verbally and in writing.
Written informed consent was obtained from all
respondents prior to inclusion. The Medical Ethical
Committee of the VU University Medical Center
approved the study.
Data were collected between November 1999 and
May 2001. All measurements were administrated in a
face-to-face interview, lasting between one and three
hours, spread over one-to-three interview sessions.
From the source population (696 nursing home
patients who met inclusion criteria) eventually an active
sample of 350 patients remained who participated in the
baseline data-collection (Jongenelis et al., 2004). Fifty-
eight patients (8.3%) died before the interview could be
started and 46 patients (6.6%) could not be interviewed
because they were mentally or physically too ill to be
interviewed; 235 patients (33.8%) refused to participate
in this study; and 7 patients (1.0%) were not included
for other reasons.
Measures
All patients were interviewed using the GDS and the
MADRS. The GDS was not self-administered because
of the frailty of the respondents. The MADRS was
based on observation and interview.
Interviewers were one nursing home physician,
two psychologists, one psychotherapist and two
registered nurses.
The presence of major depressive disorder (MaD)
and minor depression (MinD), used as reference
standard for GDS and MADRS (DSM-IV criteria:
American Psychiatric Association, 1994), was assessed
with the Schedules for Clinical Assessment in
Neuropsychiatry (SCAN) by trained interviewers
(one nursing home physician, one psychologist, one
psychotherapist, one registered nurse) (World Health
Organization, 1999).
Due to practical problems during the data-
collection, blinding the SCAN-interviewers for GDS
score was only possible in a minority of the cases
(16%). However, no important differences in results
between blinded and non-blinded interviewers were
observed.
Demographic characteristics of respondents,
including age, gender and level of education, were
gathered using a standard questionnaire.
Cognitive functioning was assessed with the
MMSE.
Information about the presence of physical illnesses
was obtained from the attending physician using a
questionnaire containing thirteen main groups of
diseases. Functional limitations were measured using
the 17 items concerning somatic autonomy of the
Sickness Impact Profile 68 (SIP 68: de Bruin, 1996).
The SIP was developed for patients with chronic
diseases and is also used in nursing home populations
(Gerety, Cornell et al., 1994).
Data analyses
Based on the SCAN results, the study-sample was
divided into three groups: no depressive disorder,
MinD and MaD.
For assessing the screening abilities of the three
GDS-versions, the sensitivity and the specificity of the
three tested GDS-versions were systematically com-
pared and expressed in terms of the Areas Under the
Curve (AUC) derived from Receiver Operator
Characteristic (ROC) curves.
To compare the GDS and the MADRS in their
ability to measure (changes in) severity of depression,
the differences in mean GDS-scores (30-, 15- and
8-item version) and in mean MADRS scores between
the three groups (MaD, MinD and no depression) were
calculated. The differences in mean scores were also
expressed as effect-sizes to facilitate the comparison of
their abilities to measure (changes in) severity of
depression (d¼m1 – m2/pooled ; d¼ effect size, m1¼
mean first group, m2¼mean second group,
¼ standard deviation) (Cohen, 1988). The larger the
effect size, the better the instrument is able to measure
(change in) severity of depression.
Results
Demographic and clinical characteristics are shown in
Table 1. About two thirds of the sample were women;
their mean age was 79.3 (SD: 8.3) years. All patients
had moderate to severe functional impairments. A
major depressive disorder was observed in 8.1% and
minor depression in 14.1% of the sample.
Complete SCAN-data, GDS-data and MADRS
data were available for 313 patients. The internal
consistency of the three used GDS versions and
the MADRS was good. Cronbach’s alpha was 0.88
for the 30-item GDS; 0.79 for the 15-item GDS; and
0.80 for the 8-item GDS. Cronbach’s alpha of the
MADRS was 0.85.
In Table 2 the results (area under the curves: AUC)
of the ROC curves of the GDS (30-, 15- and 8-item
version) are summarized. The differences between the
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AUCs of the GDS-versions for MaD, MinD and
no depression are small and well within each others’
95% confidence intervals.
Mean GDS scores (30-, 15- and 8-item version)
and mean MADRS scores are shown in Table 3.
The differences in mean GDS scores (30-, 15- and
8-item version) and in mean MADRS scores between
patients with MaD, MinD and no depression were
statistically significant (One way ANOVA: p5 0,001
for all GDS versions and for the MADRS). Differences
in mean GDS scores and mean MADRS scores
between patients with MaD and MinD and between
patients with MinD and no depression were expressed
also in effect-sizes (see Table 4). Effect-sizes of the
MADRS for both the difference between MinD and no
depression and the difference between MaD and MinD
were almost twice the effect-sizes of the three GDS
versions (30-, 15- and 8-item version) for these
differences. As can be seen, there were no large
differences in effect sizes between the three used
GDS-versions.
Discussion
Depression is a common mental disorder among
nursing home patients, with considerable negative
consequences. Sub-optimal recognition and treatment
may be improved by introducing one instrument
for screening and for assessment of treatment effects.
The present study compared three GDS-versions
(30-, 15- and 8-item interview versions) on their
efficacy to screen for major and minor depression
among nursing home patients and compared these
GDS-versions and the MADRS (based on interview
and observation) on their ability to measure (changes
in) severity of depression among nursing home
patients.
The AUCs of the GDS-versions for major
depressive disorder, minor depression and no depres-
sion were all statistically significant. The shorter
versions of the GDS performed less well than the
Table 1. Demographic and clinical characteristics of a
sample of nursing home patients in the Netherlands
(n¼ 350).
Characteristic n %
Age (mean: 79.3; SD: 8.3; range: 55–99)
55–79 169 48.3
80–99 181 51.7
Gender
Male 109 31.1
Female 241 68.9
Level of education (n¼ 348)
6 years 146 42.0
46 years 202 58.0
Cognitive functioning (MMSE)
(mean: 22.0; SD: 3.8; range 15–30)
15–23 221 63.1
24–30 129 36.9
Number of physical illnesses (n¼ 300)
(mean: 3.7; SD: 1.6; range: 1–9)
3 145 48.3
43 155 51.7
Functional impairments (n¼ 340)
Severe 148 43.5
Moderate 192 56.5
Depression (DSM IV) (n¼ 333)
Major depressive disorder (MDD) 27 8.1
Minor depression (MinD) 47 14.1
Notes: SD¼ standard deviation; MMSE¼Mini-Mental
State Examination; DSM IV¼Diagnostic and Statistical
Manual of Mental Disorders, 4th edition.
Table 3. Mean MADRS and mean GDS (30-, 15- and
8-item version) scores in patients with MaD, MinD and no
depression.
MaD MinD
No
depression
MADRS: mean (SD) 25.6 (5.2) 16.3 (6.3) 5.1 (5.2)
30-item GDS: mean (SD) 19.9 (5.3) 15.9 (5.4) 10.1 (6.3)
15-item GDS: mean (SD) 9.9 (2.7) 7.4 (3.1) 3.7 (2.7)
8-item GDS: mean (SD) 5.7 (1.8) 4.1 (2.2) 1.7 (1.8)
Notes: MADRS¼Montgomery A˚sberg Depression Rating
Scale; GDS¼Geriatric Depression Scale; MaD¼major
depressive disorder; MinD¼minor depression; SD¼
standard deviation.
Table 4. Effect-sizes of MADRS and GDS (30-, 15- and
8-item version) for the differences between MaD and MinD
and between MinD and no depression.
Effect-size:
MaD-MinD
Effect-size:
MinD-no depression
MADRS 1.61 1.94
30-item GDS 0.75 0.99
15-item GDS 0.86 1.28
8-item GDS 0.80 1.19
Notes: MADRS¼Montgomery A˚sberg Depression Rating
Scale; GDS¼Geriatric Depression Scale; MaD¼major
depressive disorder; MinD¼minor depression.
Table 2. Area Under the Curves of the GDS (30, 15 and
8 item version) in Receiver Operator Characteric curves for
MaD, MinD and no depression.
MaD MinD No depression
AUC GDS-30 0.903 0.799 0.125
(95%CI) (0.828–0.979) (0.737–0.861) (0.076–0.173)
AUC GDS-15 0.896 0.778 0.142
(95%CI) (0.820–0.971) (0.714–0.843) (0.092–0.193)
AUC GDS-8 0.879 0.757 0.164
(95%CI) (0.800–0.958) (0.681–0.834) (0.104–0.223)
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30-item version, but all GDS-versions can be viewed as
acceptable screenings-instruments, based on these data.
Both the MADRS and the GDS-versions showed
highly significant differences in mean scores between
patients with a major depressive disorder, a minor
depression or no depression. As the effect size of the
MADRS was considerably larger than the effects sizes
of the GDS-versions, the MADRS seems the most
appropriate instrument for measuring (changes in)
severity of depression and thus for assessment of
treatment effects in nursing home patients. But, because
the effect sizes of the threeGDS-versions were also quite
large, using the GDS for assessment of treatment effects
in nursing home patients still may well be possible.
Advantages of the GDS, especially of its shorter
versions, such as being easier to administer for care
personnel and consuming less time than the MADRS,
may outweigh the better performance of the MADRS
in measuring the severity of depression and are
arguments that favor use of the GDS.
In conclusion, the present investigation indicates
that in search of one short and simple instrument that
can be used both for screening and for assessment
of treatment effects in nursing home patients, the GDS
may be an acceptable candidate.
Some limitations of the study should be mentioned.
One limitation of the present study is that GDS and
MADRS were compared with rather broad diagnostic
entities: major depressive disorder, minor depression
and no depression. The severity of the major depres-
sion, for example, was not taken into account.
A second limitation is the generalizability of the
results as only a selection of patients on somatic
wards could be included. For patients on psychoger-
iatric wards and for patients with serious cognitive
impairment we need other instruments for screening
and assessment of severity as well as for diagnosing
depression.
If these future studies corroborate our findings,
screening and evaluation of treatment of depression
could be done by one instrument in patients without
severe cognitive impairments and without severe
communications problems. This would be an impor-
tant contribution to the management of depression
in nursing home.
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